trastuzumab vedotin (MRG002) / Lepu Med  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
trastuzumab vedotin (MRG002) / Lepu Med
MRG002-010, NCT05754853: A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer

Recruiting
3
290
RoW
MRG002, Docetaxel Injection, Paclitaxel Injection, Gemcitabine Hydrochloride for Injection, Pemetrexed Disodium Injection
Shanghai Miracogen Inc.
Advanced or Metastatic Urothelium Cancer
10/25
01/27
NCT04924699: A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer

Recruiting
2/3
350
RoW
MRG002, Trastuzumab Emtansine for Injection
Shanghai Miracogen Inc.
Advanced Breast Cancer, Metastatic Breast Cancer
09/23
10/23

Download Options